2019 UVA Controversies in Liver Disease and Transplantation is organized by University of Virginia (UVA) and will be held on Aug 17, 2019 at Wintergreen Resort, Nellysford, Virginia, United States of America.
The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Virginia School of Medicine designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Virginia School of Medicine and/or The University of Virginia School of Nursing Continuing Education, an accredited provider(s), awards 4.50 hours of participation (consistent with the designated number of AMA PRA Category 1 Credits™ or ANCC contact hours) to participants who successfully complete this educational activity. The University of Virginia School of Medicine and/or The University of Virginia School of Nursing Continuing Education maintains a record of participation for six (6) years.
The University of Virginia School of Nursing Continuing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The University of Virginia SONCE awards 4.50 contact hours for nurses who participate in this educational activity and complete the post-activity evaluation.
Experts in the field plan to cover topics that are highly relevant for practicing gastroenterologists, hepatologists, primary care physicians, physician assistants, nurse practitioners and anyone involved with treating liver disease patients before and after transplantation. Discussions will include nutrition, frailty and deconditioning in the transplant patient; management of the pretransplant candidate; model end-stage liver disease (MELD) and organ allocation changes; timing of transplant referrals; living donation updates; medical management of the transplant recipient; a mock selection committee and panel discussions. The program will be a half day format
At the completion of this program, participants should be able to:
• Use objective measures to evaluate transplant candidate frailty and deconditioning and be able to recognize interventions that may improve outcomes
• Recognize core concepts in the evaluation and management of the decompensated cirrhosis patient as well as understand the individualized care for specific disease processes
• Tell how changes in the organ allocation policy will affect the ability of an individual patient to be listed for liver transplantation and undergo successful transplantation
• Discuss the indications for prompt referral for transplant evaluation while understanding limitations to early or late referrals
• Identify the best indications for live donor liver transplant (LDLT) as well as the limitations in the LDLT system to include an overview of what the surgical procedure itself involves for the donor and recipient
• Express the multidisciplinary approach to the liver transplant recipient and the standard of care medical management of the successful recipient
• Describe the multifaceted approach to each liver transplant candidate and the requirements and gray zones for approval and listing for candidates
|Contact No. :||(434) 924-5310
|Registration Type||Due Date||Price|
|Physician / Fellows Early Fee||16 Jul,2019||USD 150.00|
|Other Health Care Professional Early Fee||16 Jul,2019||USD 75.00|
|Student / Resident Early Fee||16 Jul,2019||USD 15.00|